These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38689172)

  • 1. Prognostic and Predictive Significance of Ki67 in Primary Non-metastatic or Recurrent Acral Melanoma: Evidence from a Multicenter Retrospective Study.
    Liang C; Li D; Liang Y; Xie Y; Lin N; Guan H; Hu W; Guan Y; Liang Y
    Ann Surg Oncol; 2024 Jul; 31(7):4594-4604. PubMed ID: 38689172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
    Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
    Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
    Tas F; Erturk K
    Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.
    Jurmeister P; Bockmayr M; Treese C; Stein U; Lenze D; Jöhrens K; Friedling F; Dietel M; Klauschen F; Marsch W; Fiedler E; von Laffert M
    J Dtsch Dermatol Ges; 2019 Aug; 17(8):800-808. PubMed ID: 31437373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
    Wei X; Wu D; Li H; Zhang R; Chen Y; Yao H; Chi Z; Sheng X; Cui C; Bai X; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Mao L; Lian B; Kong Y; Dai J; Tang B; Yan X; Wang X; Li S; Zhou L; Balch CM; Si L; Guo J
    Ann Surg Oncol; 2020 Sep; 27(9):3478-3485. PubMed ID: 32253677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
    Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
    Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
    Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
    PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node status predicts survival in thick melanomas: the Oxford perspective.
    Rughani MG; Swan MC; Adams TS; Marshall A; Asher R; Cassell OC; Middleton MR
    Eur J Surg Oncol; 2012 Oct; 38(10):936-42. PubMed ID: 22617251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.
    Sun W; Xu Y; Yang J; Liao Z; Li T; Huang K; Patel P; Yan W; Chen Y
    Cancer Commun (Lond); 2020 Nov; 40(11):586-597. PubMed ID: 33025763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma Patients.
    Laks S; Meyers MO; Deal AM; Frank JS; Stitzenberg KB; Yeh JJ; Thomas NE; Ollila DW
    Am Surg; 2017 Sep; 83(9):972-978. PubMed ID: 28958277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
    Tas F; Erturk K
    Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological regression in melanoma: impact on sentinel lymph node status and survival.
    Aivazian K; Ahmed T; El Sharouni MA; Stretch JR; Saw RPM; Spillane AJ; Shannon KF; Ch'ng S; Nieweg OE; Thompson JF; Lo SN; Scolyer RA
    Mod Pathol; 2021 Nov; 34(11):1999-2008. PubMed ID: 34247192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal carcinomas with high MIB-1 labelling indices but low pKi67 mRNA levels correlate with better prognostic outcome.
    Duchrow M; Ziemann T; Windhövel U; Bruch HP; Broll R
    Histopathology; 2003 Jun; 42(6):566-74. PubMed ID: 12786892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in young women with cutaneous melanoma.
    Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
    Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma.
    Tas F; Erturk K
    Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-varying pattern of recurrence risk for localized melanoma in China.
    Wen X; Li D; Zhao J; Li J; Yang T; Ding Y; Peng R; Zhu B; Huang F; Zhang X
    World J Surg Oncol; 2020 Jan; 18(1):6. PubMed ID: 31901239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.